BIO Protocol cooperates with CRISPR AI to accelerate decentralized scientific innovation, and the $COVID project will be launched tomorrow

On January 8th, BIO Protocol announced a strategic cooperation with CRISPR AI to jointly promote the future development of decentralized science (DeSci). This cooperation includes the strategic allocation of Nuclease DAO to BIO Treasury, injecting new impetus into the collaboration between the two parties in the field of gene editing and distributed scientific research. This move will accelerate the innovation process in the field of DeSci.

 

In addition, Long COVID Labs ($COVID), a heavyweight project of the BIO Protocol platform, will exclusively launch on BIO Launchpad on January 9, 2025. Led by current and former Stanford University researchers, the project aims to accelerate the treatment research progress of more than 100 million long COVID-19 patients worldwide through decentralized financing.

 

BIO Protocol continues to consolidate its leadership position in the field of decentralized science through strategic cooperation and technological innovation, and its future development potential is highly anticipated!